- Home
- HCM vs BBT Comparison
HCM vs BBT Comparison
Compare HCM & BBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCM
- BBT
- Stock Information
- Founded
- HCM 2000
- BBT 1846
- Country
- HCM Hong Kong
- BBT United States
- Employees
- HCM N/A
- BBT N/A
- Industry
- HCM Biotechnology: Pharmaceutical Preparations
- BBT Banks
- Sector
- HCM Health Care
- BBT Finance
- Exchange
- HCM Nasdaq
- BBT Nasdaq
- Market Cap
- HCM 2.6B
- BBT 2.2B
- IPO Year
- HCM N/A
- BBT N/A
- Fundamental
- Price
- HCM $16.01
- BBT $24.16
- Analyst Decision
- HCM Sell
- BBT Hold
- Analyst Count
- HCM 1
- BBT 1
- Target Price
- HCM $13.75
- BBT $33.00
- AVG Volume (30 Days)
- HCM 56.9K
- BBT 537.9K
- Earning Date
- HCM 08-07-2025
- BBT 11-08-2025
- Dividend Yield
- HCM N/A
- BBT 2.23%
- EPS Growth
- HCM N/A
- BBT N/A
- EPS
- HCM 0.53
- BBT 0.88
- Revenue
- HCM $602,197,000.00
- BBT $345,393,000.00
- Revenue This Year
- HCM N/A
- BBT $53.53
- Revenue Next Year
- HCM $15.49
- BBT $73.62
- P/E Ratio
- HCM $5.91
- BBT $27.47
- Revenue Growth
- HCM N/A
- BBT 8.11
- 52 Week Low
- HCM $11.51
- BBT $22.27
- 52 Week High
- HCM $21.50
- BBT $32.36
- Technical
- Relative Strength Index (RSI)
- HCM 48.16
- BBT N/A
- Support Level
- HCM $17.19
- BBT N/A
- Resistance Level
- HCM $16.35
- BBT N/A
- Average True Range (ATR)
- HCM 0.29
- BBT 0.00
- MACD
- HCM -0.01
- BBT 0.00
- Stochastic Oscillator
- HCM 21.74
- BBT 0.00
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.